Market Realist |
Novo Nordisk: Pick Up This Diabetes Leader In 2018 - Seeking Alpha
Seeking Alpha New generation insulin products will drive Novo Nordisk's growth trajectory in 2018. The company has made rapid advances in its GLP-1 portfolio. Certain company. Diabetes Care Segment Continues to Drive Growth for NVO in 2018 Financial Newsletter - Zacks Novo Nordisk A/s - NVO - Stock Price Today - Zacks |
from diabetes - Google News
Social Plugin